Term ends Oct 17, 2036 · Low confidence
20-year base term ends Oct 17, 2036
Held by AbbVie Inc.
Filed Feb 28, 2018 as application 15/908,347 · Granted Jul 9, 2019
Base term, 20 years from filing
Today
2016
2036
Clock starts
Oct 17, 2016
Oct 17, 2016
Term ends
Oct 17, 2036
Oct 17, 2036
Granted
Jul 9, 2019
Jul 9, 2019
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,202,393, US 10,202,394, US 9,963,459, to Oct 17, 2036. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
87
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 17, 2016, when application 15/295,561, the earliest non-provisional in its chain, was filed (this one was filed Feb 28, 2018); a parent in its chain could not be resolved (the next row) | Oct 17, 2036 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,202,393, US 10,202,394, US 9,963,459) | resolves to Oct 17, 2036, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 17, 2036 | Low confidence |
This family
| Application 15/295,561 | Abandoned not computed | not computed |
| US 9,879,019 | In force Oct 2036 | Oct 2036 |
| US 9,879,018 | In force Oct 2036 | Oct 2036 |
| US 9,951,080 | In force no later than Oct 2036 | no later than Oct 2036 |
| US 9,963,459 | In force Oct 2036 | Oct 2036 |
| Application 15/891,012 | Abandoned not computed | not computed |
| US 10,017,517 | In force Oct 2036 | Oct 2036 |
| US 10,344,036 | this patent Oct 2036 | Oct 2036 |
8 of 87 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 15, 2018 Reel 47515, frame 721 | Klünder, Ben | AbbVie Deutschland GmbH & Co. KG | Assignment of Assignor's Interest |
| Nov 15, 2018 Reel 47515, frame 730 | AbbVie Deutschland GmbH & Co. KG | AbbVie Inc. | Assignment of Assignor's Interest |
| Nov 30, 2018 Reel 47638, frame 901 | Jayanth, Jayanthy; Mohamed, Mohamed-eslam F.; Othman, Ahmed A.; Marroum, Patrick J.; Mayer, Peter T. | AbbVie Inc. | Assignment of Assignor's Interest |
| Mar 14, 2019 Reel 48598, frame 748 | Allian, Ayman | AbbVie Inc. | Assignment of Assignor's Interest |
| Nov 5, 2019 Reel 50918, frame 215 | Allian, Ayman; Jayanth, Jayanthy; Marroum, Patrick J.; Mayer, Peter T.; Mohamed, Mohamed-eslam F.; Othman, Ahmed A. | AbbVie Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2036
Term ends Oct 17, 2036. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,202,393, US 10,202,394, US 9,963,459, ends no earlier than this term, so it caps nothing.
Citations
73
later US patents cite this one
That is top 5% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.